| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Theodore Ashburn | President and CEO, Director | 01 Mar 2022 | |||
| John P. McCabe | CFO and Treasurer | 01 Mar 2022 | |||
| John Mayer Goldberg | Chief Medical Officer | 01 Mar 2022 | |||
| Brian J. Shea | Interim CEO | 06 Jun 2023 | |||
| Scott A. Canute | Director | 23 Jun 2022 | |||
| Mary Kay Fenton | Director | 23 Jun 2022 | |||
| Rick Wanstall | CFO and Treasurer | 25 May 2022 | |||
| Mitchell H. Finer | Director | 23 Jun 2022 | |||
| DOUGLAS FAMBROUGH | Director | 22 Jun 2022 | |||
| Barbara Yanni | Director | 23 Jun 2022 | |||
| James E. Flynn | Possible Member of 10% Group, 10%+ Owner | 28 Dec 2022 | |||
| Eric Rubin | Director | 23 Jun 2022 | |||
| Spencer Nam | Director | 23 Jun 2022 | |||
| Luke Evnin | Director | 23 Jun 2022 | |||
| Christophe Queva | CSO and SVP, Research | 01 Mar 2022 | |||
| Stephen Harbin | COO and Chief of Staff | 01 Nov 2022 | |||
| Alexander Nolte | Interim CFO | 09 May 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|